The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pierre Fabre; Roche
REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.
 
Sophie Cousin
No Relationships to Disclose
 
Carine A. Bellera
No Relationships to Disclose
 
Jean Philippe Guégan
No Relationships to Disclose
 
Carlos A. Gomez-Roca
No Relationships to Disclose
 
Jean-Philippe Metges
Honoraria - Bristol-Myers Squibb; Lilly; Novartis; Sanofi; SynCoreBio
Travel, Accommodations, Expenses - Amgen; Amgen; LEO Pharma; MSD Oncology; MSD Oncology; MSD Oncology
 
Antoine Adenis
Honoraria - Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; SERVIER
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Simon Pernot
Honoraria - Amgen; AstraZeneca; Merck Serono; Sanofi
Consulting or Advisory Role - Amgen; Merck Serono; Pierre Fabre
Travel, Accommodations, Expenses - Amgen; Roche; Servier/Pfizer
 
Coralie Cantarel
No Relationships to Disclose
 
Michèle Kind
No Relationships to Disclose
 
Maud Toulmonde
No Relationships to Disclose
 
Kevin Bourcier
No Relationships to Disclose
 
Isabelle Soubeyran
No Relationships to Disclose
 
Alban Bessede
No Relationships to Disclose
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb